{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:17:22Z","timestamp":1784816242222,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"King Saud University, Riyadh, Saudi Arabia","award":["RSPD2025R709"],"award-info":[{"award-number":["RSPD2025R709"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99534-3","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T08:51:34Z","timestamp":1746003094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson\u2019s disease with in vitro evaluation"],"prefix":"10.1038","volume":"15","author":[{"given":"Jagdish","family":"Chand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Jupudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh F.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha Bin","family":"Emran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gomathy","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"99534_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J., Obeso, J. A. & Halliday, G. M. Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 18, 101\u2013113. https:\/\/doi.org\/10.1038\/nrn.2016.178 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"99534_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 1\u201321 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"99534_CR3","doi-asserted-by":"publisher","first-page":"1468850","DOI":"10.3389\/fphar.2024.1468850","volume":"15","author":"K Yang","year":"2024","unstructured":"Yang, K. et al. The potential of natural products to inhibit abnormal aggregation of \u03b1-Synuclein in the treatment of Parkinson\u2019s disease. Front. Pharmacol. 15, 1468850 (2024).","journal-title":"Front. Pharmacol."},{"key":"99534_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/1871527316666170124165222","volume":"16","author":"L Dezsi","year":"2017","unstructured":"Dezsi, L. & Vecsei, L. Monoamine oxidase B inhibitors in Parkinson\u2019s disease. CNS Neurol. Disord. Drug Targets 16, 425\u2013439 (2017).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"99534_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2174\/187152711797247885","volume":"10","author":"MA Cenci","year":"2011","unstructured":"Cenci, M. A., Ohlin, K. E. & Odin, P. Current options and future possibilities for the treatment of dyskinesia and motor fluctuations in Parkinson\u2019s disease. CNS Neurol. Disord.-Drug Targets 10, 670\u2013684 (2011).","journal-title":"CNS Neurol. Disord.-Drug Targets"},{"key":"99534_CR6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/pharmaceutics15051503","volume":"15","author":"DD Nakmode","year":"2023","unstructured":"Nakmode, D. D., Day, C. M., Song, Y. & Garg, S. The management of Parkinson\u2019s disease: An overview of the current advancements in drug delivery systems. Pharmaceutics 15, 1503. https:\/\/doi.org\/10.3390\/pharmaceutics15051503 (2023).","journal-title":"Pharmaceutics"},{"key":"99534_CR7","doi-asserted-by":"publisher","first-page":"1004835","DOI":"10.3389\/fchem.2022.1004835","volume":"10","author":"L Shi","year":"2022","unstructured":"Shi, L. et al. Design, synthesis and biological evaluation of 9-aryl-5H-pyrido[4,3-b]indole derivatives as potential tubulin polymerization inhibitors. Front Chem. 10, 1004835 (2022).","journal-title":"Front Chem."},{"key":"99534_CR8","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.3390\/ijms24032642","volume":"24","author":"YJ Chiu","year":"2023","unstructured":"Chiu, Y. J. et al. Investigating therapeutic effects of indole derivatives targeting inflammation and oxidative stress in neurotoxin-induced cell and mouse models of Parkinson\u2019s disease. Int. J. Mol. Sci. 24, 2642 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"99534_CR9","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3390\/molecules29092127","volume":"29","author":"E Barresi","year":"2024","unstructured":"Barresi, E. et al. Indole-based compounds in the development of anti-neurodegenerative agents. Molecules 29, 2127. https:\/\/doi.org\/10.3390\/molecules29092127 (2024).","journal-title":"Molecules"},{"key":"99534_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153281","volume":"77","author":"WJ Duan","year":"2020","unstructured":"Duan, W. J. et al. Theacrine, a purine alkaloid from kucha, protects against Parkinson\u2019s disease through SIRT3 activation. Phytomedicine 77, 153281 (2020).","journal-title":"Phytomedicine"},{"key":"99534_CR11","doi-asserted-by":"publisher","first-page":"794","DOI":"10.14336\/AD.2022.1123","volume":"14","author":"H Xu","year":"2023","unstructured":"Xu, H., Liu, Y. Y., Li, L. S. & Liu, Y. S. Sirtuins at the crossroads between mitochondrial quality control and neurodegenerative diseases: Structure, regulation, modifications, and modulators. Aging Dis. 14, 794\u2013824. https:\/\/doi.org\/10.14336\/AD.2022.1123 (2023).","journal-title":"Aging Dis."},{"key":"99534_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/biom13050735","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Role of Sirtuin 3 in degenerative diseases of the central nervous system. Biomolecules 13, 735. https:\/\/doi.org\/10.3390\/biom13050735 (2023).","journal-title":"Biomolecules"},{"key":"99534_CR13","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.14336\/AD.2023.0203","volume":"14","author":"H Xiao","year":"2023","unstructured":"Xiao, H. et al. Targeting mitochondrial sirtuins in age-related neurodegenerative diseases and fibrosis. Aging Dis. 14, 1583\u20131605 (2023).","journal-title":"Aging Dis."},{"key":"99534_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7555\/JBR.36.20220078","volume":"37","author":"H Li","year":"2023","unstructured":"Li, H. & Cai, Z. SIRT3 regulates mitochondrial biogenesis in aging-related diseases. J. Biomed. Res. 37, 77\u201388. https:\/\/doi.org\/10.7555\/JBR.36.20220078 (2023).","journal-title":"J. Biomed. Res."},{"key":"99534_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/antiox12040955","volume":"12","author":"S Chakrabarti","year":"2023","unstructured":"Chakrabarti, S. & Bisaglia, M. Oxidative stress and neuroinflammation in Parkinson\u2019s disease: The role of dopamine oxidation products. Antioxidants 12, 955. https:\/\/doi.org\/10.3390\/antiox12040955 (2023).","journal-title":"Antioxidants"},{"key":"99534_CR16","doi-asserted-by":"publisher","first-page":"38220","DOI":"10.1021\/acsomega.3c04494","volume":"8","author":"O Mafethe","year":"2023","unstructured":"Mafethe, O. et al. Pharmacophore model-based virtual screening workflow for discovery of inhibitors targeting plasmodium falciparum Hsp90. ACS Omega 8, 38220\u201338232 (2023).","journal-title":"ACS Omega"},{"key":"99534_CR17","doi-asserted-by":"publisher","first-page":"23414","DOI":"10.1038\/s41598-024-75603-x","volume":"14","author":"G Subramanian","year":"2024","unstructured":"Subramanian, G. et al. System biology-based assessment of the molecular mechanism of IMPHY000797 in Parkinson\u2019s disease: A network pharmacology and in-silico evaluation. Sci. Rep. 14, 23414 (2024).","journal-title":"Sci. Rep."},{"key":"99534_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2023.107881","volume":"105","author":"SD Ranade","year":"2023","unstructured":"Ranade, S. D. et al. Design, synthesis, molecular dynamics simulation, MM\/GBSA studies and kinesin spindle protein inhibitory evaluation of some 4-aminoquinoline hybrids. Comput. Biol. Chem. 105, 107881 (2023).","journal-title":"Comput. Biol. Chem."},{"key":"99534_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2024.101543","volume":"49","author":"JA Olanrewaju","year":"2024","unstructured":"Olanrewaju, J. A. et al. Spondias mombin flavonoids showed super-binder ability with downstream molecular targets of Parkinson\u2019s disease: A structural study. Inform. Med. Unlocked 49, 101543 (2024).","journal-title":"Inform. Med. Unlocked"},{"key":"99534_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2283161","author":"Aryan","year":"2023","unstructured":"Aryan, et al. Rational design of thiazolidine-4-one-gallic acid hybrid derivatives as selective partial PPAR\u03b3 modulators: an in-silico approach for type 2 diabetes treatment. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2283161 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"99534_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.33263\/BRIAC142.048","volume":"14","author":"G Subramanian","year":"2024","unstructured":"Subramanian, G., Jupudi, S., Chand, J., Baba, M. Z. & Aryan,. Network pharmacology approach and molecular docking prediction to investigate the possible mechanism of benzylidene derivatives against scavenging reactive oxygen species via sirtuin 3 in Parkinson\u2019s disease. Biointerface Res. Appl. Chem. 14, 48 (2024).","journal-title":"Biointerface Res. Appl. Chem."},{"key":"99534_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.22159\/ijap.2024v16i3.50628","volume":"16","author":"J Chand","year":"2024","unstructured":"Chand, J. et al. In silico, preparation and in vitro studies of benzylidene-based hydroxy benzyl urea derivatives as free radical scavengers in parkinson\u2019s disease. Int. J. Appl. Pharmaceut. 16, 217\u2013224 (2024).","journal-title":"Int. J. Appl. Pharmaceut."},{"key":"99534_CR23","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/molecules18022084","volume":"18","author":"HA Abdel-Aziz","year":"2013","unstructured":"Abdel-Aziz, H. A., Elsaman, T., Attia, M. I. & Alanazi, A. M. The reaction of ethyl 2-oxo-2H-chromene-3-carboxylate with hydrazine hydrate. Molecules 18, 2084\u20132095 (2013).","journal-title":"Molecules"},{"key":"99534_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40011-019-01122-9","volume":"90","author":"C Jerard","year":"2020","unstructured":"Jerard, C., Michael, B. P., Chenicheri, S., Vijayakumar, N. & Ramachandran, R. Rosmarinic acid-rich fraction from mentha arvensis synchronizes Bcl\/Bax expression and induces Go\/G1 arrest in hepatocarcinoma cells. Proc. Natl. Acad. Sci. India Sect. B Biol. Sci. 90, 515\u2013522 (2020).","journal-title":"Proc. Natl. Acad. Sci. India Sect. B Biol. Sci."},{"key":"99534_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55\u201363 (1983).","journal-title":"J. Immunol. Methods"},{"key":"99534_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116598","volume":"275","author":"H Sharma","year":"2024","unstructured":"Sharma, H. et al. Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer. Eur. J. Med. Chem. 275, 116598 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"99534_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0003-2697(77)90429-8","volume":"79","author":"HP Misra","year":"1977","unstructured":"Misra, H. P. & Fridovich, I. Superoxide dismutase: \u2018Positive\u2019 spectrophotometric assays\u2019. Anal. Biochem. 79, 553\u2013560 (1977).","journal-title":"Anal. Biochem."},{"key":"99534_CR28","doi-asserted-by":"crossref","unstructured":"Ruocco, M. R. et al. Diclofenac-induced apoptosis in the neuroblastoma cell line SH-SY5Y: Possible involvement of the mitochondrial superoxide dismutase. J. Biomed. Biotechnol. 2010, (2010).","DOI":"10.1155\/2010\/801726"},{"key":"99534_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells11060930","volume":"11","author":"ER Trzeciak","year":"2022","unstructured":"Trzeciak, E. R. et al. Oxidative stress differentially influences the survival and metabolism of cells in the melanoma microenvironment. Cells 11, 801726 (2022).","journal-title":"Cells"},{"key":"99534_CR30","doi-asserted-by":"publisher","first-page":"096032712210892","DOI":"10.1177\/09603271221089257","volume":"41","author":"CM Lee","year":"2022","unstructured":"Lee, C. M. et al. An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species. Hum. Exp. Toxicol. 41, 096032712210892 (2022).","journal-title":"Hum. Exp. Toxicol."},{"key":"99534_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21228609","volume":"21","author":"CSS Teixeira","year":"2020","unstructured":"Teixeira, C. S. S., Cerqueira, N. M. F. S. A., Gomes, P. & Sousa, S. F. A molecular perspective on sirtuin activity. Int. J. Mol. Sci. 21, 1\u201320. https:\/\/doi.org\/10.3390\/ijms21228609 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"99534_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jchemneu.2017.11.009","volume":"95","author":"Anamika","year":"2019","unstructured":"Anamika, Khanna, A., Acharjee, P., Acharjee, A. & Trigun, S. K. Mitochondrial SIRT3 and neurodegenerative brain disorders. J. Chem. Neuroanat. 95, 43\u201353. https:\/\/doi.org\/10.1016\/j.jchemneu.2017.11.009 (2019).","journal-title":"J. Chem. Neuroanat."},{"key":"99534_CR33","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.7150\/thno.45922","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target. Theranostics 10, 8315\u20138342. https:\/\/doi.org\/10.7150\/thno.45922 (2020).","journal-title":"Theranostics"},{"key":"99534_CR34","doi-asserted-by":"publisher","first-page":"5074367","DOI":"10.1155\/2019\/5074367","volume":"2019","author":"PC Wei","year":"2019","unstructured":"Wei, P. C. et al. Neuroprotection of indole-derivative compound NC001-8 by the regulation of the NRF2 pathway in Parkinson\u2019s disease cell models. Oxid. Med. Cell Longev. 2019, 5074367 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"key":"99534_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.arr.2018.03.004","volume":"44","author":"J Lv","year":"2018","unstructured":"Lv, J. et al. PGC-1\u03b1 sparks the fire of neuroprotection against neurodegenerative disorders. Ageing Res. Rev. 44, 8\u201321. https:\/\/doi.org\/10.1016\/j.arr.2018.03.004 (2018).","journal-title":"Ageing Res. Rev."},{"key":"99534_CR36","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1021\/acs.jmedchem.3c01979","volume":"67","author":"C Lambona","year":"2024","unstructured":"Lambona, C., Zwergel, C., Valente, S. & Mai, A. SIRT3 activation a promise in drug development? New insights into SIRT3 biology and its implications on the drug discovery process. J. Med. Chem. 67, 1662\u20131689. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01979 (2024).","journal-title":"J. Med. Chem."},{"key":"99534_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2019.105414","volume":"135","author":"MA Mart\u00ednez","year":"2020","unstructured":"Mart\u00ednez, M. A. et al. Use of human neuroblastoma SH-SY5Y cells to evaluate glyphosate-induced effects on oxidative stress, neuronal development and cell death signaling pathways. Environ. Int. 135, 105414 (2020).","journal-title":"Environ. Int."},{"key":"99534_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/oxygen2020006","volume":"2","author":"G Martemucci","year":"2022","unstructured":"Martemucci, G. et al. Free radical properties, source and targets, antioxidant consumption and health. Oxygen 2, 48\u201378 (2022).","journal-title":"Oxygen"},{"key":"99534_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112891","volume":"209","author":"AM Pisoschi","year":"2021","unstructured":"Pisoschi, A. M. et al. Oxidative stress mitigation by antioxidants\u2014An overview on their chemistry and influences on health status. Eur. J. Med. Chem. 209, 112891. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112891 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"99534_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.5530\/ijper.57.2.68","volume":"57","author":"G Subramanian","year":"2023","unstructured":"Subramanian, G., Chand, J., Jupudi, S. & Prudviraj, P. Synthesis and biological evaluation of the selected naphthalene substituted azetidinone derivatives targeting Parkinson\u2019s disease. Indian J. Pharmaceut. Educ. Res. 57, 552\u2013558 (2023).","journal-title":"Indian J. Pharmaceut. Educ. Res."},{"key":"99534_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101107","volume":"62","author":"ZD Zhou","year":"2020","unstructured":"Zhou, Z. D. & Tan, E. K. Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson\u2019s disease. Ageing Res. Rev. 62, 101107. https:\/\/doi.org\/10.1016\/j.arr.2020.101107 (2020).","journal-title":"Ageing Res. Rev."},{"key":"99534_CR42","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/antiox11112155","volume":"11","author":"R Aggarwal","year":"2022","unstructured":"Aggarwal, R., Potel, K. N., McFalls, E. O., Butterick, T. A. & Kelly, R. F. Novel therapeutic approaches enhance PGC1-alpha to reduce oxidant stress-inflammatory signaling and improve functional recovery in hibernating myocardium. Antioxidants 11, 2155. https:\/\/doi.org\/10.3390\/antiox11112155 (2022).","journal-title":"Antioxidants"},{"key":"99534_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/ars.2018.7620","volume":"31","author":"H Feng","year":"2019","unstructured":"Feng, H. et al. Peroxisome proliferator-activated receptor-\u03b3coactivator-1\u03b1 inhibits vascular calcification through Sirtuin 3-mediated reduction of mitochondrial oxidative stress. Antioxid Redox Signal 31, 75\u201391 (2019).","journal-title":"Antioxid Redox Signal"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99534-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T08:51:37Z","timestamp":1746003097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99534-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99534"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99534-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15196"}}